Effect of Platelet Inhibition with Cangrelor during PCI on Ischemic EventsDeepak L. Bhatt, Robert A. Harrington, Matthew J. Price et al.|New England Journal of Medicine|2013Cited by 825
Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary SyndromesPierluigi Tricoci, Kenneth W. Mahaffey, Zhen Huang et al.|New England Journal of Medicine|2011Cited by 753
De-escalation to ticagrelor monotherapy versus 12 months of dual antiplatelet therapy in patients with and without acute coronary syndromes: a systematic review and individual patient-level meta-analysis of randomised trialsMarco Valgimigli, Myeong‐Ki Hong, Sung‐Jin Hong et al.|The Lancet|2024Cited by 93